Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
38%
Ph phase_2
1
8%
Ph phase_1
2
15%
Ph phase_3
4
31%
Ph early_phase_1
1
8%

Phase Distribution

3

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
2(15.4%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
4(30.8%)
N/ANon-phased studies
5(38.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(9)
Other(2)

Detailed Status

Completed9
unknown2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (7.7%)
Phase 12 (15.4%)
Phase 21 (7.7%)
Phase 34 (30.8%)
N/A5 (38.5%)

Trials by Status

unknown215%
completed969%
not_yet_recruiting215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
13